Mereo BioPharma (MREO) Leases (2022 - 2025)
Mereo BioPharma (MREO) has disclosed Leases for 4 consecutive years, with $244000.0 as the latest value for Q4 2025.
- Quarterly Leases fell 66.44% to $244000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $244000.0 through Dec 2025, down 66.44% year-over-year, with the annual reading at $244000.0 for FY2025, 66.44% down from the prior year.
- Leases for Q4 2025 was $244000.0 at Mereo BioPharma, down from $378000.0 in the prior quarter.
- The five-year high for Leases was $1.7 million in Q4 2022, with the low at $244000.0 in Q4 2025.
- Average Leases over 4 years is $844100.0, with a median of $818000.0 recorded in 2024.
- The sharpest move saw Leases decreased 26.76% in 2023, then plummeted 66.44% in 2025.
- Over 4 years, Leases stood at $1.7 million in 2022, then decreased by 26.76% to $1.2 million in 2023, then tumbled by 41.61% to $727000.0 in 2024, then crashed by 66.44% to $244000.0 in 2025.
- According to Business Quant data, Leases over the past three periods came in at $244000.0, $378000.0, and $522000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.